🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
1.000
+0.090 (9.89%)
Nov 19, 2026, 4:00 PM EST - Market closed

Aardvark Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
22286---
Market Cap Growth
-90.30%----
Enterprise Value
-38160---
Last Close Price
1.0013.13---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.382.68---
P/TBV Ratio
0.382.68---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.000.010.020.02
Net Debt / Equity Ratio
-1.04-1.03-1.01-1.08-0.99
Net Debt / EBITDA Ratio
0.791.753.20--
Net Debt / FCF Ratio
0.902.024.011.691.50
Quick Ratio
8.5810.4314.957.2327.07
Current Ratio
9.1110.6115.057.5027.72
Return on Equity (ROE)
-80.85%-64.44%-50.70%-57.47%-
Return on Assets (ROA)
-73.48%-59.16%-46.77%-52.82%-80.94%
Return on Capital Employed (ROCE)
-131.50%-58.80%-31.40%-81.00%-64.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-333.16%-20.15%---
FCF Yield
-305.30%-18.99%---
Buyback Yield / Dilution
-43.78%-391.06%-0.90%-1.78%-
SEC Filings: 10-K · 10-Q